Insights from 2023 ASH Annual Meeting
ASH 2023 Insights: "Results From AGAVE-201 - Axatilimab at 3 Different Doses in Pts With Chronic GVHD"
By
Insights from 2023 ASH Annual Meeting
FEATURING
Daniel Wolff
By
Insights from 2023 ASH Annual Meeting
FEATURING
Daniel Wolff
Login to view comments.
Click here to Login
